02:01 AM EDT, 10/18/2026 (MT Newswires) -- Biosergen (BIOSGN.ST) is one step closer to finalizing its merger with its life science investor Flerie (FLERIE.ST) after securing the Swedish Companies Registration Office's approval. The merger is set to take effect on Friday after its registration on the same day, according to an Oct. 16 release. As such, the biotechnology company noted that its last trading day will be on Thursday, with delisting to follow on Friday. The company added that it will become part of Flerie's newly formed unit, Flerie Invest. Biosergen shareholders are expected to receive the new shares as part of the merger consideration on Oct. 28.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.